BrightSpring Health Services (BTSG) Investor Day 2026 summary

Strategic Overview and Business Model

• Focuses on integrated Home and Community health services, combining Pharmacy and Provider businesses for comprehensive, high-ROI care aligned with long-term healthcare trends and serving seniors and specialty populations.

• Expanded from pre-IPO to a scaled, integrated healthcare platform through rebranding, acquisitions, and divestitures, including the planned divestiture of Community Living by Q1 2026 and acquisition of home health assets.

• Opened 150 de novo locations and completed 76 profitable M&A transactions since 2018, leveraging operational, quality, and commercial investments for geographic and service expansion.

• Integrated care model delivers services in lower-cost settings, enabling cross-referrals, value-based care, and competitive advantages in a consolidating industry.

• Positioned to address unmet needs in large, growing, fragmented markets with high-quality, integrated services and a focus on operational excellence and scale.

Pharmacy and Provider Business Details

• Pharmacy segment includes Specialty (Onco360, CareMed), Infusion (Amerita), and Home & Community Pharmacy (PharMerica), dispensing over 40 million scripts annually and ranking among the top 10 U.S. pharmacies.

• Specialty Pharmacy is a national leader in oncology, rare, and orphan disease therapies, with exclusive manufacturer partnerships and over 24 new drug launches in 2025.

• Infusion business is a top provider in acute and chronic home infusion, expanding through organic growth, M&A, and alternate site strategies.

• Home & Community Pharmacy is evolving from a SNF-centric model to targeted growth in assisted living, IDD, and hospice, leveraging automation and technology for efficiency.

• Provider segment covers Home Health, Hospice, Rehab, and Personal Care, with strong quality metrics, geographic expansion, and integration with payer and ACO models.

Growth Drivers and Market Trends

• Operates in large, fragmented, and growing markets, benefiting from demographic trends such as the aging population and rising chronic conditions.

• Growth strategies include organic expansion, geographic reach, platform efficiencies, integrated care, and disciplined M&A, with a balanced approach across Pharmacy and Provider segments.

• Investments in technology, AI, and process automation are central to driving operational efficiency, quality, and scalability.

• Maintains a robust M&A pipeline, averaging 10-15 deals per year, with a focus on accretive tuck-ins and selective larger transactions.

• Strategic divestitures and platform optimization support long-term growth and financial flexibility.